Business
Press Release Mar 23 2023
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 23, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 23, 2023, titled \"Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005% 0.064%\". View Attachment","length":385,"tagName":"div"}]